TMCnet News
Global Vaccine Adjuvants Market, 2021 - Increasing Use Of Recombinant Subunit And Synthetic Vaccines - Research and MarketsResearch and Markets has announced the addition of the "Global Vaccine Adjuvants Market" report to their offering. The global market for Vaccine Adjuvants was estimated to be worth USD 4,100 million, in the year 2016. It poised to reach USD 5,565 million by the end of 2021, growing at an estimated CAGR of 6.3% during the forecast period of 2016-2021 The Adjuvants are pharmacological or immunological agents that helps in synergizing and directing the adaptive immune response to vaccine agents. Adjuvants are generally classified based on their source, mechanism of action and physical or chemical properties. Adjuvants can be broadly classified into three groups that is active immunostimulants, carriers, and vehicle adjuvants. Understanding the application of adjuvants is very imperative in analyzing the market dynamics. This study targets at gaining a detailed verview of the market dynamics of the contemporary market and during the forecast period for the vaccine adjuvants market. Adjuvants basically enhance the specific immune response against co-inoculated antigens. The Adjuvants market in study has been segmented based on type and mechanism of action. The segmentation based on type includes Mineral Salt based adjuvants, Tensoactive agents, Emulsions, Liposomes, Carbohydrate adjuvants, Bacterial Products, Non-Bacterial organics (Squalene), Saponins, Cytokines, Virosomes, TLR based adjuvants, and Others. Key Topics Covered: 1. Introduction 2. Research Methodology 3. Market Dynamics 4. Market Segmentation 5. Competitive Landscape 6. Company Profiles 7. Analyst Outlook For Investment Opportunity 8. Future Outlook Of The Market Companies Featured
For more information about this report visit http://www.researchandmarkets.com/research/gwsz8b/global_vaccine Related Topics: Vaccines
View source version on businesswire.com: http://www.businesswire.com/news/home/20160823006159/en/ |
